Ludwig And Agenus To Begin Development Of Promising Antibodies BioResearch Online (press release) Ludwig Cancer Research and Agenus Inc. announced that the companies are advancing three selected monoclonal antibody checkpoint modulators (CPMs) into preclinical development. Agenus plans to develop the CPMs into single agents and in optimized ... Investors Not Happy With Agenus Inc (NASDAQ:AGEN) |
